Nile Therapeutics (NLTX) Receives Minimum Bid Notice from Nasdaq

Nile Therapeutics, Inc. (Nasdaq: NLTX) today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2). The Company...

Read More